Fiche centre
Royal Perth Hospital
Perth — Australia
Essais liés5clinical trials
VillePerthlocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07362446
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| CTX001 | Maladie rénale chronique | Phase 1 | NCT07901933 | Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease | NOT_YET_RECRUITING |
| Physiology-guided NCL PCI | Maladie coronarienne | Non applicable | NCT05701358 | COMPLETE-2 — Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease | ACTIVE_NOT_RECRUITING |
| Rituximab | SEP | Phase 3 | NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | COMPLETED |
| Symplicity Spyral™ multi-electrode renal denervation system | Maladie rénale chronique | Non applicable | NCT07115953 | Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension | RECRUITING |
| Xolatryp | Maladie coronarienne | Phase 2 | NCT07362446 | PROTECT-MI — Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction | RECRUITING |